Table 1 NHI price list of antihypertensive drugs
| Â | Drug name | Listed price as of April 2012 | Listed date of FDC drugs |
|---|---|---|---|
ARB+HCTZ FDC | losartan (50 mg) + hydrochlorothiazide (6.25 mg) | 146.4 | December 2006 |
| Â | valsartan (80 mg) + hydrochlorothiazide (6.25 mg) | 120.9 | March 2009 |
| Â | candesartan (8 mg) + hydrochlorothiazide (6.25 mg) | 143.6 | March 2009 |
| Â | telmisartan (40 mg) + hydrochlorothiazide (6.25 mg) | 137.9 | June 2009 |
ARB+CCB FDC | valsartan (80 mg) + amlodipine (5 mg) | 120.3 | April 2010 |
| Â | olmesartan (20 mg) + azelnidipine (16 mg) | 158.1 | April 2010 |
| Â | candesartan (8 mg) + amlodipine (5 mg) | 140.7 | June 2010 |
| Â | telmisartan (40 mg) + amlodipine (5 mg) | 133.2 | September 2010 |
ARB | losartan (50 mg) | 143.4 | Â |
| Â | valsartan (80 mg) | 114.8 | Â |
| Â | candesartan (8 mg) | 140.4 | Â |
| Â | telmisartan (40 mg) | 131.0 | Â |
| Â | olmesartan (20 mg) | 130.4 | Â |
HCTZ | hydrochlorothiazide (25 mg) | 5.6 | Â |
CCB | amlodipine (5 mg) | 23.1 | Â |
| Â | azelnidipine (16 mg) | 65.5 | Â |